The bluSONIL IV Therapy Experience The bluSONIL IV therapy experience is designed to feel different from the moment you arrive
The evidence around GLP-1s and sarcopenia is often conflicting, with some studies finding no change to skeletal muscle mass, while others indicate accelerated muscle degradation due to rapid weight loss (Uchiyama, 2023
Contact your healthcare provider promptly if: Back pain persists beyond 23 weeks despite conservative measures Pain progressively worsens rather than improving Pain significantly interferes with daily activities or sleep Systemic symptoms develop (fever, night sweats) or unintentional weight loss beyond therapy goals Pain occurs in patients with cancer history or other risk factors for metastatic disease Flank pain accompanied by urinary symptoms (possible kidney stones or infection) Clinicians should obtain a thorough history, perform physical examination, and consider laboratory evaluation (including serum lipase and liver function tests) when indicated
Want help spotting the more subtle ways you may be restricting without realizing it
All findings referenced are from peer-reviewed preclinical studies
179 At present, studies on whether diabetes and IR aggravate ER stress in PD are few